These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9767620)
1. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia. Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324 [TBL] [Abstract][Full Text] [Related]
4. KL-6: a serum marker for interstitial pneumonia. Kobayashi J; Kitamura S Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858 [TBL] [Abstract][Full Text] [Related]
5. [CA19-9-producing idiopathic pulmonary fibrosis with diffuse alveolar damage and a high titer of KL-6--an autopsy case]. Shimizu Y; Tanaka Y; Sasaki A; Nemoto T Nihon Kokyuki Gakkai Zasshi; 2001 May; 39(5):351-6. PubMed ID: 11510099 [TBL] [Abstract][Full Text] [Related]
6. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Ishii H; Mukae H; Kadota J; Kaida H; Nagata T; Abe K; Matsukura S; Kohno S Thorax; 2003 Jan; 58(1):52-7. PubMed ID: 12511721 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease. Suzuki K; Takada H; Oka S; Kanouzawa S; Iimuro M; Kitazumi Y; Arima T; Ohyama R; Kuwayama H Intern Med; 2003 Aug; 42(8):650-4. PubMed ID: 12924486 [TBL] [Abstract][Full Text] [Related]
8. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases. Fukaya S; Oshima H; Kato K; Komatsu Y; Matsumura H; Ishii K; Miyama H; Nagai T; Tanaka I; Mizutani A; Katayama M; Yoshida S; Torikai K Rheumatol Int; 2000; 19(6):223-5. PubMed ID: 11063292 [TBL] [Abstract][Full Text] [Related]
9. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282 [TBL] [Abstract][Full Text] [Related]
10. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia]. Kobayashi J; Itoh Y; Kitamura S; Kawai T Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361 [TBL] [Abstract][Full Text] [Related]
11. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia]. Kohno N Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia. Arai Y; Obinata K; Sato Y; Hisata K; Tadokoro R; Tawa T; Kinoshita K Eur J Pediatr; 2001 Jul; 160(7):425-9. PubMed ID: 11475580 [TBL] [Abstract][Full Text] [Related]
13. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases]. Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity. Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980 [TBL] [Abstract][Full Text] [Related]
15. KL-6 as a serum marker for amiodarone-induced pulmonary toxicity. Kohno N; Yokoyama A; Kondo K Intern Med; 2000 Dec; 39(12):1004-5. PubMed ID: 11197780 [No Abstract] [Full Text] [Related]
16. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. Satoh H; Kurishima K; Ishikawa H; Ohtsuka M J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248 [TBL] [Abstract][Full Text] [Related]
17. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Bandoh S; Fujita J; Ohtsuki Y; Ueda Y; Hojo S; Tokuda M; Dobashi H; Kurata N; Yoshinouchi T; Kohno N; Takahara J Ann Rheum Dis; 2000 Apr; 59(4):257-62. PubMed ID: 10733471 [TBL] [Abstract][Full Text] [Related]